489 related articles for article (PubMed ID: 8650585)
21. Anti-proteinase 3 antibodies, their characterization and disease associations.
Jennings JG; Chang L; Savige JA
Clin Exp Immunol; 1994 Feb; 95(2):251-6. PubMed ID: 8306500
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
[TBL] [Abstract][Full Text] [Related]
25. Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3.
Badakere SS; Pradhan VD; Almeida AF; Pawar AR
J Fluoresc; 2004 Jul; 14(4):459-63. PubMed ID: 15617388
[TBL] [Abstract][Full Text] [Related]
26. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
[TBL] [Abstract][Full Text] [Related]
27. [Antineutrophil cytoplasmic antibodies as marker and follow-up parameter of vasculitis and glomerulonephritis].
Wüthrich RP
Praxis (Bern 1994); 1994 Oct; 83(43):1202-6. PubMed ID: 7973270
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic and prognostic significance of ANCA.
Lesavre P
Ren Fail; 1996 Sep; 18(5):803-12. PubMed ID: 8903094
[TBL] [Abstract][Full Text] [Related]
29. The pathogenic role of antineutrophil cytoplasmic autoantibodies.
Ewert BH; Jennette JC; Falk RJ
Am J Kidney Dis; 1991 Aug; 18(2):188-95. PubMed ID: 1651049
[TBL] [Abstract][Full Text] [Related]
30. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
[TBL] [Abstract][Full Text] [Related]
32. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
[TBL] [Abstract][Full Text] [Related]
33. Antineutrophil cytoplasmic autoantibodies antigen specificity.
Lesavre P
Am J Kidney Dis; 1991 Aug; 18(2):159-63. PubMed ID: 1714231
[TBL] [Abstract][Full Text] [Related]
34. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
35. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.
Gross WL; Schmitt WH; Csernok E
Am J Kidney Dis; 1991 Aug; 18(2):175-9. PubMed ID: 1867175
[TBL] [Abstract][Full Text] [Related]
36. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
[TBL] [Abstract][Full Text] [Related]
37. A study of anti-neutrophil cytoplasm antibodies in systemic vasculitis and other related disorders.
Pradhan VD; Badakere SS; Iyer YS; Kumar R; Almeida AF
J Postgrad Med; 2003; 49(1):5-9; discussion 9-10. PubMed ID: 12865563
[TBL] [Abstract][Full Text] [Related]
38. Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops.
Savige JA; Davies DJ; Gatenby PA
Pathology; 1994 Apr; 26(2):186-93. PubMed ID: 8090592
[TBL] [Abstract][Full Text] [Related]
39. Anti-myeloperoxidase antibodies in patients with microscopic polyangiitis.
Pradhan VD; Badakere SS; Pawar AR; Almeida AF
Indian J Med Sci; 2003 Nov; 57(11):479-86. PubMed ID: 14646155
[TBL] [Abstract][Full Text] [Related]
40. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
